DRUG NAME Generic Name: Sulodexide Brand Name: Vessel due F

DOSAGE 250 LSU, 1 cap TID

CLASSIFICA TION Anticoagulan t, Antithrombot ics Fibrinolytics

INDICATION Vascular pathologies w/ thrombotic risk, transient ischemic attacks &cerebrovas cular disease, peripheral vascular insufficiency, diabetic retinopathy, MI, retinal vasal thrombosis.

CONTRAINDIC ATION Hypersensitivity to sulodexide, heparin & heparin- like products. Diathesis & hemorrhagic diseases.

SIDE-EFFECTS GI disorders: nausea vomiting epigastralgia Pain burn hematoma at the site of injection. chills fever urticaria

NSG. RESPONSIBILITIES Assess patients for signs of bleeding and hemorrhage (bleeding gums; nosebleed; unusual bruising; black, tarry stools; hematuria; fall in hematocrit or blood pressure; guaiacpositive stools). Notify physician if these occur. Monitor patient for hypersensitivity reactions (chills, fever, urticaria). Report signs to physician Monitor platelet count every 2-3 days throughout therapy. May cause mild thrombocytopenia, which appears on the 4th day and resolves despite continued heparin therapy.

DRUG NAME Generic Name: Omeprazol e Brand

DOSAGE 20mg capsule BID

CLASSIFICA TION Antisecretory agent Proton pump inhibitor

INDICATION Short-term treatment of active duodenal ulcer First-

CONTRAINDICA TION Contraindicated with hypersensiti vity to omeprazole or its components.

SIDE-EFFECTS Dizziness headache nausea, vomiting, diarrhea symptoms of

NSG. RESPONSIBILITIES Advise the patient to take the drug before meals. Swallow the capsules whole; do not chew, open, or crush them. If using the oral

Name: Phaisom

line therapy in treatment of heartburn or symptoms of GERD Shortterm treatment of active benign gastric ulcer GERD, severe erosive esophagiti s, poorly responsive symptoma tic GERD Longterm therapy: Treatment of pathologic hypersecr etory conditions (ZollingerEllison syndrome, multiple adenomas, systemic mastocyto sis) Eradicat ion

upper respiratory tract infection, cough

suspension, empty packet into a small cup containing 2 tablespoons of water. Stir and drink immediately; fill cup with water and drink this water. Do not use any other liquid or food to dissolve the packet. This drug will need to be taken for up to 8 weeks (short-term therapy) or for a prolonged period (> 5 years in some cases). Advise patient to maintain proper nutrition Advise patient not to self-medicate instead consult with health care provider if uncomfortable Report severe headache, worsening of symptoms, fever, chills. Advise the client to have a regular medical followup visits.

of Helicob acter pylori with amoxicillin or metroni dazole and clarithrom ycin Prilosec OTC: Treat ment of frequent heartburn (2 or more days per week) Unlabel ed use: Posterior laryngitis; enhance efficacy of pancrea tin for the treatment of steatorr hea in cystic fibrosis

DRUG NAME Generic Name: Acetylcysteine Brand Name: Flumicil

DOSAGE 600mg 1 tab, diluted in 50 ml H2O OD

CLASSIFICA TION Antidote

INDICATION Adjunct therapy for abnormal viscid or thickened mucous

CONTRAINDICA TION Contraindicat ed in patients hypersensitiv e to drug. Use cautiously in

SIDE-EFFECTS CNS: fever, drowsiness, abnormal thinking, gait disturbance

NSG. RESPONSIBILITIES Observe 10 rights in drug administration. Use plastic, glass, stainless steel, or another nonreactive metal when giving by

secretions in patients with pneumonia, bronchitis, bronchiectasi s, primary amyloidosis of the lung, tuberculosis, cystic fibrosis, emphysema, atelectasis, pulmonary complications of thoracic surgery, or CV surgery Adults and children: 1 to 2 ml 10% or 20% solution by direct instillation into trachea as often as q hour. Or, 1 to 10 ml of 20% solution or 2 to 20 ml of 10% solution by nebulization q 2 to 6 hours, prn Acetamino phen toxicity Adults and children: Initially, 140

elderly or debilitated patients with severe respiratory insufficiency. Use I.V. formulation cautiously in patients with asthma or a history of bronchospas m.

s CV: tachycardia, hypotension , hypertensio n, flushing, chest tightness EENT: rhinorrhea, ear pain, eye pain, pharyngitis, throat tightness GI: stomatitis, nausea, vomiting Respiratory: rhonchi, bronchospa sm, cough, dyspnea Skin: rash, clamminess, diaphoresis, pruritus, urticaria Other: angioedema , chills, anaphylacto id reaction

nebulization. Hand-bulb nebulizers arent recommended because output is too small and particle size too large. Inform patient that drug is physically or chemically incompatible with tetracyclines, erythromycin lactobionate, amphotericin B, and ampicillin sodium. If given by aerosol inhalation, nebulize these drugs separately. Iodized oil, trypsin, and hydrogen peroxide are physically incompatible with acetylcysteine; dont add to nebulizer. Drug smells strongly of sulfur. Mixing oral form with juice or cola improves its taste. Drug delivered through nasogastric tube may be diluted with water. Monitor cough type and frequency. Be aware that facial erythema may occur within 30 to 60 minutes after the start of an I.V. infusion and usually resolves without infusion interruption.

mg/kg P.O. then 70 mg/kg P.O. q 4 hours for 17 doses. Or, a loading dose of 150mg/kg IV over 15 minutes; then IV maintenance dose of 50 mg/kg infused over 4 hours, followed by 100 mg/kg infused over 16 hours.

DRUG NAME Generic Name: Losartan Potassium Brand Name: Speronolocton e

DOSAG E 25/2 mg 1 tab OD in HM

CLASSIFICAT ION Angiotensin II receptor blocker (ARB) Antihypertensi ve

INDICATION Treatment of hypertensi on, alone or in combinati on with other antihypert ensive agents Treatment of diabetic neuropath y with an elevated

CONTRAINDICATI ON Use cautiously with hepatic or renal dysfunction, hypovolemia.

SIDE-EFFECTS Dizziness headache nausea, vomiting, diarrhea symptoms of upper respiratory tract infection cough

NSG. RESPONSIBILITIES Administer without regard to meals. Ensure that patient is not pregnant before beginning therapy, suggest using barrier birth control while using losartan; fetal injury and deaths have been reported. Find an

serum creatinine and proteinuria in patients with type 2 (non insulindependent ) diabetes and a history of hypertensi on

alternative method of feeding the baby if given to a nursing mother. Depression of the reninangiotensin system in infants is potentially very dangerous. Alert surgeon and mark patient's chart with notice that losartan is being taken. The blockage of the renin-angiotensin system following surgery can produce problems. Hypotension may be reversed with volume expansion. Monitor patient closely in any situation that may lead to a decrease in blood pressure secondary to reduction in fluid volume excessive perspiration, dehydration, vomiting, diarrhea

excessive hypotension can occur.